Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 192431011000036114 | Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 192432011000036115 | Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | Is a | Sandostatin LAR | true | Inferred relationship | Some | ||
| Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | Is a | octreotide 20 mg modified release injection, 20 mg vial (medicinal product unit of use) | true | Inferred relationship | Some | ||
| Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | has Australian BoSS | octreotide | true | Inferred relationship | Some | 708528428 | |
| Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | has manufactured dose form | modified release injection | true | Inferred relationship | Some | ||
| Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | has intended active ingredient | octreotide | true | Inferred relationship | Some | 708528428 | |
| Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | has unit of use | vial | true | Inferred relationship | Some | 708528429 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sandostatin LAR (1 x 20 mg vial, 1 x 2.5 mL inert diluent syringe), 1 pack | has TPUU | True | Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | Inferred relationship | Some | 1 |
| Sandostatin LAR (1 x 20 mg vial, 1 x 2.5 mL inert diluent syringe), 1 pack | has TPUU | True | Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | Inferred relationship | Some | 1 |
| Sandostatin LAR (1 x 20 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | has TPUU | True | Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | Inferred relationship | Some | 2 |
| Sandostatin LAR (1 x 20 mg vial, 1 x 2 mL inert diluent syringe), 1 pack | has TPUU | True | Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR